CTOs on the Move

Innovatient Solutions

www.innovatient.com

 
Innovatient helps healthcare organizations deliver better care through an interactive patient experience and engagement technology platform. The highly customizable software provides an easy-to-use solution delivered via TV, tablet, or bedside monitor engaging patients during treatment and after they go home, fostering an environment of wellness and improved outcomes. Our integrated nurse rounding, communication, and patient education tools result in improved patient satisfaction scores (HCAHPS) transforming the patient experience creating long-term relationships with healthcare providers.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Humco Holding Group

Humco Holding Group, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Humco Holding Group, Inc. is based in Texarkana, TX. You can find more information on Humco Holding Group, Inc. at www.humco.com

Dart NeuroScience

At Dart NeuroScience we are visionaries` innovators` and optimists. We are not a typical pharmaceutical company. We are a discovery catalyst` perfectly positioned and structured to make a serious difference in our world. Curious and creative` hopeful and driven – all joined together to fulfill our vision: protect and enhance the quality of mind. With open minds and open hearts` we stretch our limits every day so that we can continue to improve life and the way we live it.

Stride Autism Centers

Stride Autism Centers is a provider of Applied Behavior Analysis (ABA) therapy for preschool children with autism in Illinois, Iowa, and Nebraska.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

Emergency Care Programs

Emergency Care Programs is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.